INmune Bio Inc. (INMB)
INMB trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.68
-5.62% on the day
Market cap
$46.6M
Nano cap
Revenue · 2025
$50K
+257.1% on 2024
Net income · 2025
-$46.0M
-92000.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | INMB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001711754 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $50K |
| Net income | -$46.0M |
| Operating income | -$47.4M |
| Net margin | -92000.0% |
| Operating margin | -94766.0% |
| Revenue growth | +257.1% |
| Cash | $24.8M |
| Total assets | $32.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 932.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-12-19 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-30 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-06 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-14 |
| Latest proxy PROXY STATEMENT | DEF 14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 597 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| BSEM | BioStem Technologies Inc. | $2.25 | -7.79% | $42.0M |
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| TIL | Instil Bio Inc. | $6.18 | -6.08% | $41.9M |
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier